Skip to content

comparison of two regimens of misoprostol for termination of early pregnancy failure.

comparison of two regimens of misoprostol for termination of early pregnancy failure.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230605001
Enrollment
150
Registered
2023-06-05
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early pregnancy failure Early pregnancy failure, misoprostol, vaginal, sublingual

Interventions

Misoprostol 800 microgram vaginal supposition every 3 hours (maximum 2 doses),Misoprostol 600 microgram sublingual every 3 hours (maximum 2 doses)
Treatment,Treatment
Misoprostol 800 microgram vaginal supposition,Misoprostol 600 microgram sublingual

Sponsors

Vachira Phuket Medical Education Center
Lead Sponsor
Vachira Phuket hospital
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. gestational age less than 13 weeks 2. singleton pregnancy 3. small amounts of vaginal bleeding or no no vaginal bleeding 4. no pelvic pain or mild degree of pelvic pain 5. normal vital signs

Exclusion criteria

Exclusion criteria: 1. underlying disease that Prostaglandin drugs aggravate symptoms such as asthma and heart disease 2. allergic to Prostaglandin drugs 3. suspected ectopic pregnancy 4.have had an abortion induced before.

Design outcomes

Primary

MeasureTime frame
success rate of drug use to inducecompleted abortion 24 hours metric

Secondary

MeasureTime frame
induction to complete expulsion interval minutes metric

Countries

Thailand

Contacts

Public ContactSupapun Wattanacharoen

vachiraphuket hospital

doctor_air@yahoo.com0815426726

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026